BNP Paribas Financial Markets’s Tvardi Therapeutics TVRD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $44.2K | Buy |
|
|||||
|
2025
Q2 | $7K | Buy |
|
|||||
|
2025
Q1 | $177 | Sell |
|
|||||
|
2024
Q4 | $81.8K | Sell |
|
|||||
|
2024
Q3 | $179K | Sell |
|
|||||
|
2024
Q2 | $278K | Buy |
|
|||||
|
2024
Q1 | $260K | Sell |
|
|||||
|
2023
Q4 | $218K | Buy |
|
|||||
|
2023
Q3 | $113K | Sell |
|
|||||
|
2023
Q2 | $220K | Buy |
|
|||||
|
2023
Q1 | $307K | Buy |
|
|||||
|
2022
Q4 | $141K | Sell |
|
|||||
|
2022
Q3 | $330K | Buy |
|
|||||
|
2022
Q2 | $208K | Sell |
|
|||||
|
2022
Q1 | $403K | Sell |
|
|||||
|
2021
Q4 | $442K | Sell |
|
|||||
|
2021
Q3 | $858K | Buy |
|
|||||
|
2021
Q2 | $450K | Buy |
|
|||||
|
2021
Q1 | $355K | Buy |
|
|||||
|
2020
Q4 | $196K | Buy |
|
|||||
|
2020
Q3 | $122K | Buy |
|
|||||
|
2020
Q2 | $25.2K | Sell |
|
|||||
|
2020
Q1 | $164K | Buy |
|
|||||
|
2019
Q4 | $75.9K | Sell |
|
|||||
|
2019
Q3 | $109K | Buy |
|
|||||
|
2019
Q2 | $78.2K | Sell |
|
|||||
|
2019
Q1 | $133K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $21.1K | Sell |
|
|||||
|
2018
Q2 | $18.5K | Sell |
|
|||||
|
2018
Q1 | $70.5K | Buy |
|
|||||
|
2017
Q4 | $67.3K | Buy |
|
|||||
|
2017
Q3 | $31.4K | Sell |
|
|||||
|
2017
Q2 | $37.7K | Buy |
|
|||||
|
2017
Q1 | $405 | Sell |
|
|||||
|
2016
Q4 | $1.48K | Sell |
|
|||||
|
2016
Q3 | $11.6K | Buy |
|
|||||
|
2016
Q2 | $3.79K | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $64.7K | Sell |
|
|||||
|
2015
Q3 | $57.1K | Buy |
|
|||||
|
2015
Q2 | $16.9K | Buy |
|
|||||
|
2015
Q1 | $1.34K | Buy |
|
|||||
|
2014
Q4 | – | Sell |
|
|||||
|
2014
Q3 | $998 | Sell |
|
|||||
|
2014
Q2 | $5.04K | Buy |
|